CLINICAL_TRIALS
trial_result
· 2014-11-24
Clinical Trial Update: Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression [Phase 3]
Summary
Phase 3 trial evaluating atazanavir/ritonavir monotherapy as maintenance in virologically suppressed HIV-1 patients completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: IRCCS San Raffaele | Conditions: HIV-1 Infection | Phase 3 | Status: COMPLETED | Results posted: 2014-11-24